Catalio Capital Management, Lp Top Holdings and 13F Report (2026)

About Catalio Capital Management, Lp

Investment Activity

Catalio Capital Management, Lp has $478.70 million in total holdings as of March 31, 2026.
Catalio Capital Management, Lp owns shares of 41 different stocks, but just 19 companies or ETFs make up 80% of its holdings.
Approximately 35.41% of the portfolio was purchased this quarter.
About 52.45% of the portfolio was sold this quarter.
This quarter, Catalio Capital Management, Lp has purchased 45 new stocks and bought additional shares in 12 stocks.
Catalio Capital Management, Lp sold shares of 13 stocks and completely divested from 14 stocks this quarter.

Largest Holdings

DIANTHUS THERAPEUTICS INC: $47,021,047
BridgeBio Pharma: $32,081,360
Ascendis Pharma A/S: $29,531,559
Bristol Myers Squibb: $25,517,093
Syndax Pharmaceuticals: $24,380,131

Largest New Holdings this Quarter

10806X102 - BridgeBio Pharma: $32,081,360 Holding
24477V105 - DEFINIUM THERAPEUTICS INC: $19,617,898 Holding
45337C102 - Incyte: $17,139,346 Holding
221015100 - Corvus Pharmaceuticals: $13,048,980 Holding
922967104 - VERADERMICS INC: $10,961,703 Holding

Largest Purchases this Quarter

BridgeBio Pharma: 432,014 shares (about $32.08M)
DEFINIUM THERAPEUTICS INC: 1,037,984 shares (about $19.62M)
Incyte: 182,101 shares (about $17.14M)
Ultragenyx Pharmaceutical: 688,247 shares (about $14.42M)
Terns Pharmaceuticals: 272,073 shares (about $14.34M)

Largest Sales this Quarter

Gilead Sciences: 125,407 shares (about $17.48M)
Bristol Myers Squibb: 227,172 shares (about $13.78M)
Supernus Pharmaceuticals: 195,446 shares (about $10.10M)
DIANTHUS THERAPEUTICS INC: 93,264 shares (about $7.83M)
ABIVAX SA: 51,321 shares (about $5.71M)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
DIANTHUS THERAPEUTICS INC	$47,021,047	$7,826,715 â–¼	-14.3%	560,308	9.8%	COM
BBIO BridgeBio Pharma	$32,081,360	$32,081,360 â–²	New Holding	432,014	6.7%	Medical
ASND Ascendis Pharma A/S	$29,531,559	$2,252,076 â–²	8.3%	129,111	6.2%	Medical
BMY Bristol Myers Squibb	$25,517,093	$13,777,982 â–¼	-35.1%	420,727	5.3%	Medical
SNDX Syndax Pharmaceuticals	$24,380,131	$3,577,280 â–¼	-12.8%	1,043,670	5.1%	Medical
GILD Gilead Sciences	$22,843,440	$17,477,974 â–¼	-43.3%	163,905	4.8%	Medical
TERN Terns Pharmaceuticals	$21,564,114	$14,343,688 â–²	198.7%	409,031	4.5%	Medical
DEFINIUM THERAPEUTICS INC	$19,617,898	$19,617,898 â–²	New Holding	1,037,984	4.1%	COM SHS
SLNO Soleno Therapeutics	$19,345,012	$7,280,829 â–²	60.4%	577,808	4.0%	Medical
BSX Boston Scientific	$18,782,205	$3,834,653 â–¼	-17.0%	299,318	3.9%	Medical
RARE Ultragenyx Pharmaceutical	$17,824,197	$14,418,775 â–²	423.4%	850,797	3.7%	Medical
INCY Incyte	$17,139,346	$17,139,346 â–²	New Holding	182,101	3.6%	Medical
CYTK Cytokinetics	$14,203,671	$2,826,221 â–¼	-16.6%	215,501	3.0%	Medical
NTRA Natera	$14,180,691	$1,726,714 â–²	13.9%	70,907	3.0%	Medical
CRVS Corvus Pharmaceuticals	$13,048,980	$13,048,980 â–²	New Holding	891,933	2.7%	Medical
GPCR Structure Therapeutics	$12,309,268	$119,440 â–²	1.0%	255,379	2.6%	Medical
MLYS Mineralys Therapeutics	$11,893,621	$2,903,831 â–²	32.3%	439,041	2.5%	Medical
EW Edwards Lifesciences	$11,580,129	$3,398,675 â–¼	-22.7%	144,607	2.4%	Medical
VERADERMICS INC	$10,961,703	$10,961,703 â–²	New Holding	173,582	2.3%	COMMON STOCK
ADPT Adaptive Biotechnologies	$10,032,242	$1,365,945 â–¼	-12.0%	722,784	2.1%	Medical
HEARTFLOW INC	$9,819,296	$7,049,155 â–²	254.5%	403,588	2.1%	COM
KALV KalVista Pharmaceuticals	$8,586,472	$8,586,472 â–²	New Holding	426,551	1.8%	Medical
QURE uniQure	$8,029,747	$3,315,306 â–²	70.3%	491,116	1.7%	Medical
IRON Disc Medicine	$7,863,213	$802,511 â–²	11.4%	122,978	1.6%	Medical
SEPTERNA INC	$7,073,471		0.0%	294,360	1.5%	COM
ABIVAX SA	$5,254,941	$5,714,594 â–¼	-52.1%	47,193	1.1%	SPONSORED ADS
DYNE THERAPEUTICS INC	$5,129,956	$4,292,477 â–¼	-45.6%	282,954	1.1%	COM
ELDN Eledon Pharmaceuticals	$5,050,633	$1,170,388 â–²	30.2%	1,639,816	1.1%	Medical
KARYOPHARM THERAPEUTICS INC	$5,000,239	$4,203,818 â–²	527.8%	897,709	1.0%	COM NEW
SUPN Supernus Pharmaceuticals	$3,205,762	$10,102,603 â–¼	-75.9%	62,019	0.7%	Medical
TARA Protara Therapeutics	$3,021,925	$4,513,058 â–¼	-59.9%	580,024	0.6%	Medical
PHAT Phathom Pharmaceuticals	$2,752,691	$5,013,154 â–¼	-64.6%	247,767	0.6%	Medical
NAMS NewAmsterdam Pharma	$2,674,564	$2,674,564 â–²	New Holding	83,554	0.6%	Medical
TYRA Tyra Biosciences	$2,577,016	$2,577,016 â–²	New Holding	67,285	0.5%	Medical
IMCR Immunocore	$2,543,213	$2,543,213 â–²	New Holding	84,352	0.5%	Medical
FRACTYL HEALTH INC	$2,514,176		0.0%	5,491,866	0.5%	COM
HYPR Hyperfine	$1,425,644		0.0%	1,320,041	0.3%	Medical
METAGENOMI THERAPEUTICS INC	$708,851		0.0%	528,993	0.1%	COM
ATAIBECKLEY INC	$696,877	$696,877 â–²	New Holding	196,858	0.1%	COM SHS
SENSEI BIOTHERAPEUTICS INC	$463,911		0.0%	14,718	0.1%	COM NEW
OUTSET MED INC	$454,191		0.0%	118,279	0.1%	COM NEW
BRIDGEBIO ONCOLOGY THERAPEUT	$0	$31,414,443 â–¼	-100.0%	0	0.0%	COM NEW
LLY Eli Lilly and Company	$0	$27,858,930 â–¼	-100.0%	0	0.0%	Medical
JNJ Johnson & Johnson	$0	$25,007,838 â–¼	-100.0%	0	0.0%	Medical
REGN Regeneron Pharmaceuticals	$0	$22,999,410 â–¼	-100.0%	0	0.0%	Medical
ISRG Intuitive Surgical	$0	$15,410,089 â–¼	-100.0%	0	0.0%	Medical
ADMA ADMA Biologics	$0	$10,295,769 â–¼	-100.0%	0	0.0%	Medical
ACLX Arcellx	$0	$10,178,307 â–¼	-100.0%	0	0.0%	Medical
OCUL Ocular Therapeutix	$0	$8,674,042 â–¼	-100.0%	0	0.0%	Medical
OLMA Olema Pharmaceuticals	$0	$6,676,450 â–¼	-100.0%	0	0.0%	Medical
GRAIL INC	$0	$2,594,490 â–¼	-100.0%	0	0.0%	COM
FULC Fulcrum Therapeutics	$0	$2,276,714 â–¼	-100.0%	0	0.0%	Medical
BILLIONTOONE INC	$0	$2,087,329 â–¼	-100.0%	0	0.0%	CL A
PALVELLA THERAPEUTICS INC NE	$0	$1,094,011 â–¼	-100.0%	0	0.0%	COM
ATAI Atai Beckley	$0	$805,149 â–¼	-100.0%	0	0.0%	Medical

Showing largest 100 holdings. View all holdings.

More Institutional Buying and Selling Information

SEC Filings and Trading Data

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Catalio Capital Management, Lp Top Holdings and 13F Report (2026)

About Catalio Capital Management, Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Catalio Capital Management, Lp Top Holdings and 13F Report (2026)

About Catalio Capital Management, Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Map of 500 Largest Holdings ofCatalio Capital Management, Lp

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools